Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
74.29
-2.79 (-3.62%)
Sep 23, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $3.26 billion as of September 23, 2026. Its market cap has increased by 38.82% in one year.
Market Cap
3.26B
Enterprise Value
2.90B
1-Year Change
38.82%
Ranking
Category
Stock Price
$74.29
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $3.26B, an increase of 957.97%. That is a compound annual growth rate of 48.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 3.26B | -6.20% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 3.85B |
| IDEAYA Biosciences | 3.71B |
| Tango Therapeutics | 3.67B |
| Enliven Therapeutics | 3.62B |
| Legend Biotech | 3.41B |
| Viking Therapeutics | 3.38B |
| Arcus Biosciences | 3.21B |
| Dyne Therapeutics | 3.20B |